Chemical Structure : MET inhibitor Compound 1
货号: PC-60929Not For Human Use, Lab Use Only.
MET inhibitor Compound 1 is a potent, selective orally bioavailable MET tyrosine kinase inhibitor with IC50 of <1 nM and 12 nM for unphosphorylated and phosphorylaed MET, respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MET inhibitor Compound 1 is a potent, selective orally bioavailable MET tyrosine kinase inhibitor with IC50 of <1 nM and 12 nM for unphosphorylated and phosphorylaed MET, respectively.
MET inhibitor Compound 1 demonstrates potent, broad spectrum activity against MET mutants (V1110I, H1112Y, L1195V, Y1235D, D1228H and M1250T) with IC50 of <1 nM-57 nM, and Y1230 mutants with moderate potency (IC50=25-280 nM).
MET inhibitor Compound 1 displays >50-fold selectivity in a panel of 130 kinases with exception of Fms and TrkA/B/C.
MET inhibitor Compound 1 inhibits MET-dependent tumor cell growth in vivo through decreasing phosphorylaed MET.
分子量 | 449.426 | |
分子式 | C21H17F2N9O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Farrell PJ, et al. Mol Cancer Ther. 2017 Jul;16(7):1269-1278.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright